Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Active, not recruiting · NCT06676319 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-09-22 | NCT06676319 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sanofi | 254 |
59 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.